ASEP Medical Holdings, Inc. engages in the acquisition of assets, technology, and businesses in the area of life sciences and medical diagnostics. The company is headquartered in Victoria, British Columbia. The company went IPO on 2021-11-22. The firm consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. The firm offers a rare combination of both a novel diagnostic and a therapeutic approach. The Company’s lead product was developed through its subsidiary, Sepset Biosciences Inc., which utilizes proprietary diagnostic tools to enable the early and timely identification of sepsis. ABT Innovations Inc. provides broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections. SafeCoat Medical Inc. provides an antimicrobial peptide, anti-fouling medical device coating technology.
Follow-Up Questions
Qui est le CEO de Asep Medical Holdings Inc ?
Dr. Robert Hancock est le Chief Executive Officer de Asep Medical Holdings Inc, il a rejoint l'entreprise depuis 2021.
Quelle est la performance du prix de l'action SEPSF ?
Le prix actuel de SEPSF est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Asep Medical Holdings Inc ?
Asep Medical Holdings Inc appartient à l'industrie N/A et le secteur est N/A
Quelle est la capitalisation boursière de Asep Medical Holdings Inc ?
La capitalisation boursière actuelle de Asep Medical Holdings Inc est de $0
